MTHFR - What It Is, Why It Matters, and What to Actually Do About It

MTHFR is not a rare genetic condition. Variants that reduce methylation efficiency affect the majority of people to some degree. The practical consequence is that the standard forms of folate and B12 do not convert efficiently in those individuals, leading to elevated homocysteine, impaired neurotransmitter production, and a reduced capacity to process certain compounds. Most people who have it do not know, because it is not tested in standard bloodwork and the downstream effects get attributed to other causes.

MTHFR stands for methylenetetrahydrofolate reductase, a name that matters less than what the gene does. It produces an enzyme essential for the methylation cycle. A variation in this gene reduces how efficiently that enzyme works. Depending on which variation you have and whether you inherited it from one or both parents, the efficiency of your methylation cycle may be reduced by 30 to 70 percent compared to someone without the variation.

The consequences extend throughout the body. Elevated homocysteine, an amino acid that accumulates when methylation is sluggish, is associated with neuroinflammation, mood disorders, and cardiovascular risk. Neurotransmitter production is affected because methylation is required to synthesize serotonin and dopamine. Detoxification is compromised. People with untreated MTHFR variations often describe a background feeling of being physiologically behind, like they are working harder than other people just to feel normal.

MTHFR — what normal and impaired methylation look like Normal methylation Folic acid converted to active form Homocysteine cleared efficiently Neurotransmitters produced normally Standard supplements work adequately The conversion step is not blocked MTHFR variant — impaired methylation Conversion reduced 30 to 70% Homocysteine accumulates Neurotransmitter production constrained Standard B vitamins deliver little benefit Solution: use the methylated forms directly

Finding out is straightforward: a simple genetic test covers the most clinically significant variants. Homocysteine on a blood panel provides a functional measure of whether methylation is running efficiently regardless of genetic status. If homocysteine is elevated, the methylation cycle is not keeping up, whether or not a genetic variant is confirmed. The intervention follows from the previous post: switch from standard B12 and folate to the methylated forms. For most people, this single change produces noticeable improvements. Additional cofactor support is sometimes needed and is best guided by a practitioner familiar with methylation.

"MTHFR is not a rare condition. It affects the majority of people to some degree. For those who have it and do not know, it explains why the standard supplement recommendations have never quite worked the way they were supposed to."

The most practical first step with MTHFR is to test the output rather than the gene. Homocysteine on a standard blood panel reflects how well the methylation cycle is running, elevated homocysteine indicates the cycle is not keeping pace, regardless of which genetic variant is present. If homocysteine is elevated, switching to the methylated forms of B12 and folate is the primary intervention. Riboflavin is frequently overlooked, the MTHFR enzyme itself requires B2 to function, and B2 deficiency can limit the response even when B12 and folate are properly methylated. Working through this with a practitioner who has looked at the labs is better than working through it alone.

Product note

MTHFR slows the conversion of standard B vitamins by 30 to 70 percent. Taking folic acid and cyanocobalamin with a significant MTHFR variant is not underdosing — it is taking forms the body cannot reliably convert. Pure Encapsulations (code 654104) formulates with methylfolate and methylcobalamin throughout. The conversion step that MTHFR blocks is bypassed entirely.

Contains affiliate links
© 2026 Dr. Tommy Siu / Siu Chiropractic · siuchiropractic.com